Next quarter’s earnings estimate for CYTOF is -$0.54 with a range of -$0.54 to -$0.54. The previous quarter’s EPS was -$1.97. CYTOF beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.84% of the time in the same period. In the last calendar year CYTOF has Outperformed its overall industry.

CYTOF Sales Forecast

Next quarter’s sales forecast for CYTOF is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYTOF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.61% of the time in the same period. In the last calendar year CYTOF has Preformed in-line its overall industry.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Altamira Therapeutics

Currently, no data available

Please return soon. This page is being updated.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CYTOF Analyst Recommendation Trends

Rating

Jul 16

Aug 16

Nov 16

Jun 17

Oct 18

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CYTOF has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CYTOF average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

CYTOF Stock Forecast FAQ

What is CYTOF’s average 12-month price target, according to analysts?

Currently, no data Available

What is CYTOF’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CYTOF, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CYTOF a Buy, Sell or Hold?

Currently, no data Available

What is Altamira Therapeutics’s price target?

Currently, no data Available

What do analysts say about Altamira Therapeutics?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of CYTOF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing